Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin knob-hole interaction sites are the fundamental structural interfaces that drive the polymerization of fibrinogen into a fibrin mesh during blood coagulation (Weisel JW, 2005, Adv Protein Chem). This process begins when thrombin cleaves fibrinopeptides A and B from the central E-region of fibrinogen, exposing N-terminal 'knobs' known as A-knobs and B-knobs. These knobs specifically dock into complementary 'holes' (a-holes and b-holes) located in the C-terminal D-regions of adjacent fibrin molecules (Spraggon G, et al., 1997, Nature). The A-a interaction is primarily responsible for the longitudinal assembly of protofibrils, while the B-b interaction contributes to lateral aggregation and fiber thickening (Litvinov RI, et al., 2005, Blood). Because these interactions are essential for the formation and stability of a thrombus, they represent a significant therapeutic target for the development of next-generation anticoagulants. Small molecule or peptide mimetics, such as Gly-Pro-Arg-Pro (GPRP), bind to these holes to competitively inhibit fibrin assembly. This approach offers a mechanism to prevent or dissolve pathological clots without necessarily affecting the enzymatic activity of thrombin or other coagulation factors.
Competitive inhibition of fibrin monomer polymerization by binding to the 'hole' pockets in the D-nodule, preventing the 'knob' sequences in the E-nodule from docking (Litvinov RI, et al., 2005, Blood).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin knob-hole interaction sites.